Related Experiment Video
Updated: Jul 3, 2026
07:33
Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
[Therapeutic or prophylactic antifungal vaccination: problems and solutions]
1Klinik und Poliklinik für Dermatologie und Allergologie, Klinikum Innenstadt, Ludwig-Maximilians-Universität München, Frauenlobstrasse 9-11, 80337, München, Deutschland. Susanne.Boneberger@med.uni-muenchen.de
Summary
Fungal infections are rising in immunocompromised patients. Future vaccines may need to target cellular immunity, as traditional vaccines may be less effective against fungal pathogens.
Area of Science:
- Immunology
- Mycology
- Vaccinology
Context:
- Increasing incidence of fungal infections in immunosuppressed populations, including organ transplant recipients and patients undergoing antineoplastic chemotherapy.
- Growing global significance of fungal diseases necessitates advanced therapeutic and preventative strategies.
- Limitations of current prophylactic measures against opportunistic fungal pathogens.
Purpose:
- To highlight the increasing challenge posed by fungal infections in vulnerable patient groups.
- To underscore the need for novel vaccine strategies tailored to fungalpathogen characteristics.
- To address the potential inadequacy of conventional vaccine approaches for fungal diseases.
Summary:
- Fungal infections are a growing concern globally, particularly in patients with compromised immune systems due to organ transplantation or chemotherapy.
- Future clinical research will likely focus on genetically engineered vaccines, building upon preclinical findings.
- Classic vaccine strategies may prove insufficient for fungal infections due to the predominantly cellular immune responses fungi elicit.
Impact:
- Informs the direction of future research and development in antifungal vaccines.
- Emphasizes the critical need for innovative approaches to combat rising fungal infections.
- Suggests a shift towards vaccines that stimulate robust cellular immunity for effective fungal disease prevention.
Related Concept Videos
01:51Vaccinations
Overview
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.